RxDoctor Payments Data

Alina Bridges, DO

Dermatology · Rochester, MNNPI 1427035682

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $8,625 of the $10,700 with a category attached, or 80.6%. Argenx US, Inc. accounts for 83.2% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2023 at $8,775 and has fallen 84.3% since, to $1,378 in 2025. Among dermatology clinicians in MN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,700in general payments, 2019–2025

Across 27 payments — averaging $396.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Argenx US, Inc.$9K
  • Biofrontera Inc.$1K
  • Johnson & Johnson$130
  • Incyte Corporation$102
  • Sun Pharmaceutical Industries Inc.$63
  • Sanofi$51
  • plus $104 from 4 others
$1,100in research payments, 2019–2025

Across 3 payments — averaging $366.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Janssen Research & Development, LLC$1K

What the payments were for

  • Consulting fees$8,62581%
  • Travel & lodging$8458%
  • Food & beverage$1,22911%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,700 in reported general payments places this provider in the 90th percentile of 273 dermatology providers in Minnesota.

See all dermatology providers in Minnesota

Medicare billing

Part B allowed, 2024
$37,934
Medicare patients
243
Services billed
727

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole19$351

Paid to pharmacies, not to this prescriber.

Other dermatology in Rochester

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →